Skip to content
Alliance for Clinical Trials in Oncology
  • How Alliance Works
    • Membership
    • Leadership & Administration
    • Mission and History
    • Group Meetings
    • Careers
    • Support Our Work
  • Programs & Committees
    • Programs
    • Committees
  • Clinical Trials & Research
    • Clinical Trials
    • Trial Pathways
    • International Collaborations
    • Specimen Bank and Data Sharing Requests
    • Publications
    • Past Trial and Result Summaries
    • Safety and Standards
    • Alliance Data Innovation Lab
  • Patients
  • Contact
  • Donate
  • News
  • Member Login
    • Contact
    • Donate
    • News
    Member Login
    • How Alliance Works
      • How Alliance Works Overview
      • Membership
      • Leadership & Administration
      • Mission and History
      • Group Meetings
      • Careers
      • Support Our Work
    • Programs & Committees
      • Programs & Committees Overview
      • Programs
      • Committees
    • Clinical Trials & Research
      • Clinical Trials & Research Overview
      • Clinical Trials
      • Trial Pathways
      • International Collaborations
      • Specimen Bank and Data Sharing Requests
      • Publications
      • Past Trial and Result Summaries
      • Safety and Standards
      • Alliance Data Innovation Lab
    • Patients
    1. Home
    2. Breast Cancer
    3. Page 3

    Breast Cancer

    • Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

      September 26, 2026

      Breast Cancer
    • Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer

      September 26, 2026

      Breast Cancer
    • Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer

      September 26, 2026

      Breast Cancer
    • Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer

      September 26, 2026

      Breast Cancer
    • Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831

      September 26, 2026

      Breast Cancer
    • Gene Expression Profiling and Genetic Analysis of Tissues From Patients With Breast Cancer

      September 26, 2026

      Breast Cancer
    • Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

      September 26, 2026

      Breast Cancer
    • Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer

      September 26, 2026

      Breast Cancer
    • Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial

      September 26, 2026

      Breast Cancer
    • Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

      September 26, 2026

      Breast Cancer
    Previous
    1 2 3 4 5 6
    Next

    Categories


    Alliance Committee


    Browse by Year

    Alliance for Clinical Trials in Oncology
    • About
    • Contact
    • Disclaimer
    • Trials
    • Careers
    NCI National Clinical Trials Network | a National Cancer Institute program
    NCI Community Oncology Research Program | A program of the National Cancer Institute of the National Institutes of Health

    • Facebook
    • X
    • YouTube
    • LinkedIn

    Copyright © 2026